• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Latest News

Image credit: Saiful52 | stock.adobe.com
FDA’s Oncologic Drugs Advisory Committee Recommends Earlier Treatment with Carvykti for Relapsed or Refractory Multiple Myeloma

March 18th 2024

In a unanimous decision, the committee recommended Carvykti based on promising data from the Phase III CARTITUDE-4 study, which showed a positive risk-benefit assessment.

AI’s Impact on CEO/Founder Sustainability
AI’s Impact on CEO/Founder Sustainability

March 18th 2024

Image credit: ArtemisDiana | stock.adobe.com
Precision Medicine: Investments and Outcomes Expected

March 18th 2024

stock.adobe.com
New Report Shows AI Improved Treatments for Biofilm Infections

March 18th 2024

Conference Coverage

View All
Image credit: Design Cells | stock.adobe.com
Novartis' Lutathera Shows Significant Survival Benefit as First-Line Treatment for GEP-NETs

January 19th 2024

Eisai
Eisai To Present New Data For Gastrointestinal Cancer Research at ASCO GI 2024

January 17th 2024

Image credit: Lucky Ai | stock.adobe.com
Presentation at J.P. Morgan Healthcare Conference Highlights Growth of Platform for AI, Data

January 15th 2024

stock.adobe.com
Dexcom Announces Preliminary and Unaudited Revenue For Fourth Quarter and Fiscal Year 2023

January 12th 2024

Latest Videos
Podcasts

All News